首页 | 本学科首页   官方微博 | 高级检索  
检索        

吡格列酮抑制载脂蛋白E基因敲除小鼠主动脉粥样硬化病变进展及可能机制
引用本文:达娃次仁,赵锋,齐永芬,霍勇.吡格列酮抑制载脂蛋白E基因敲除小鼠主动脉粥样硬化病变进展及可能机制[J].中国动脉硬化杂志,2008,16(3):197-200.
作者姓名:达娃次仁  赵锋  齐永芬  霍勇
作者单位:1. 北京大学第一医院心内科,北京市,100034
2. 北京大学医学部心血管研究所,北京市,100083
摘    要:目的观察吡格列酮对高脂饲料喂养的载脂蛋白E基因敲除小鼠主动脉粥样硬化病变及其血浆脂联素水平的影响,以探讨噻唑烷二酮类药物抗动脉粥样硬化作用及其可能的机制。方法取9只17周龄雄性C57BL/6J小鼠普通饲料喂养4周为对照组;另取31只同周龄雄性载脂蛋白E基因敲除小鼠随机分成三组给予高脂饲料喂养4周,其中模型组(n=10)单用高脂饲料喂养,低剂量治疗组(n=10)经胃管给予吡格列酮10 mg/(kg.d),高剂量治疗组(n=11)经胃管给予吡格列酮20 mg/(kg.d)。所有试验小鼠均观察其主动脉粥样硬化病变及血脂、血浆脂联素水平。结果与对照组比,所有载脂蛋白E基因敲除小鼠血脂水平显著升高并伴有主动脉内膜明显增厚及内膜下粥样斑块形成;与对照组(18.96±4.89μg/L)比,模型组血浆脂联素水平(12.41±3.84μg/L)显著下降,而两治疗组脂联素水平(18.78±7.24和24.00±4.71μg/L)比模型组显著升高,主动脉粥样硬化病变却减轻,且这种变化在高剂量治疗组更明显。结论吡格列酮抑制载脂蛋白E基因敲除小鼠主动脉粥样硬化病变的进展可能与其提高血浆脂联素水平有关。

关 键 词:病理学与病理生理学  载脂蛋白E基因敲除小鼠  动脉粥样硬化  脂联素  吡格列酮
收稿时间:2007/12/13 0:00:00
修稿时间:2008/3/6 0:00:00

Anti-atherosclerotic Effects and Possible Mechanism of Pioglitazone on Apolipoprotein E Knockout Mice
DA Wa-Ci-Ren,ZHAO Feng,QI Yong-Fen,and HUO Yong.Anti-atherosclerotic Effects and Possible Mechanism of Pioglitazone on Apolipoprotein E Knockout Mice[J].Chinese Journal of Arteriosclerosis,2008,16(3):197-200.
Authors:DA Wa-Ci-Ren  ZHAO Feng  QI Yong-Fen  and HUO Yong
Institution:1.Department of Cardiology,First Hospital of Peking University,Beijing 100034;2.Institute of Cardiology,Peking University Health Science Center,Beijing 100083
Abstract:Aim To investigate the change of aortic atherosclerosis and plasma adiponectin of apolipoprotein E knockout(ApoE-/-) mouse treated with piogitazone. Methods 9 male mice of C57BL,17 weeks aged,were fed with common food for 4 weeks as simple control group.In addition,31 same age male mice of ApoE-/-were fed with high fatty food for setting up atherosclerosis animal models,and these mice were divided into three groups at random including:model group only receiving high fatty food for 4 weeks,low-dose treated group receiving piogitazone administered via gastric tube at 10 mg/(kg·d) for consecutive 4 weeks,high-dose treated group receiving piogitazone administered via gastric tube at 20 mg/(kg·d) for consecutive 4 weeks.The change of aortic atherosclerosis and levels of plasma adiponectin,plasma lipids of all mice were analyzed. Results The plasma levels of total cholesterol, low density lipoprotein cholesterol and high density lipoprotein cholesterol in all ApoE-/-mice were significantly increased than those in control group(P<0.01);The plasma adiponectin level in model group was significantly decreased than that of control group,but the plasma adiponectin was elevated and the lesions of aortic atherosclerosis were inhibited in two treated groups,moreover,these change were more significant in highdose treated group(P<0.05). Conclusions Pioglitazone inhibits aortic atherosclerosis in ApoE-/-mice,and these effects may be related to plasma adiponectin level increasing.
Keywords:Apolipoprotein E Knockout Mice  Atheroslcerosis  Adiponectin  Piogitazone
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国动脉硬化杂志》浏览原始摘要信息
点击此处可从《中国动脉硬化杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号